KVD900 as a Single Dose, Rapid, Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary Angioedema Attacks: Pharmacokinetic and Pharmacodynamic results from a Phase 1 Single Ascending Dose Study
Hampton, Sally L., De Donatis, Gian Marco, Murugesan, Nivetha I., Rushbrooke, Louise J., Li, Lily, Duckworth, Edward, Smith, Michael D., Morten, Rachel M., Maetzel, Andreas, Yea, Christopher M., FeeneVolume:
143
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2018.12.118
Date:
February, 2019
Fichier:
PDF, 81 KB
2019
File converter
Plus de résultats de recherche
More benefits 
